Beginning July 6, both traditional Medicare and Medicare Advantage plans will cover diagnostic COVID-19 laboratory tests for nursing home residents and patients through the remainder of the public health emergency, the Centers for Medicare & Medicaid Services announced Friday.

The Centers for Disease Control and Prevention recently recommended testing all nursing home residents and patients with COVID-19 symptoms or potential exposure. MA plans must continue not to charge cost sharing (including deductibles, copayments and coinsurance) or apply prior authorization or other utilization management requirements for COVID-19 tests and testing-related services, CMS notes.

Related News Articles

Headline
The Department of Health and Human Services through Sept. 24 has reduced by 52.8% its backlog of Medicare appeals at the Administrative Law Judge level,…
Headline
The Food and Drug Administration today authorized for emergency use the first serology test to help identify individuals with antibodies to SARS-CoV-2 at the…
Headline
Two clinical trials launched in April to evaluate convalescent plasma as a treatment for patients hospitalized with COVID-19 are expanding, the National…
Headline
The Centers for Medicare & Medicaid Services today announced $165 million in supplemental funding to help 33 states participating in the Money Follows…
Headline
The Centers for Disease Control and Prevention today awarded $200 million in Coronavirus Aid, Relief, and Economic Security Act funds to help states,…
Headline
Johnson & Johnson today said  that its COVID-19 vaccine candidate is moving to a global phase 3 clinical trial. The JNJ-78436735 vaccine candidate,…